CATest

CAT for Healthcare Professionals

click here to print this page

The COPD Assessment Test

These two brief webcasts provide background to the COPD Assessment Test (CAT)—a short, simple, validated questionnaire for measuring health status in COPD patients. The CAT can be used alongside measures such as lung function to give a more complete picture of how COPD affects a patient.

By using the CAT patients should be better able to describe the impact COPD has on them. Healthcare professionals should then have greater patient insight to support optimisation of patient care.

Introduction to the COPD Assessment Test

  • This webcast contains an introduction to the COPD Assessment Test (CAT) as a validated tool to improve COPD consultations and why it was developed, presented by Professor David Price, Primary Care Respiratory Society UK, Professor of Primary Care Respiratory Medicine at the University of Aberdeen.
  • Click here to view this webcast

Practical use of the COPD Assessment Test in clinical practice

  • This webcast contains practical guidance on how the COPD Assessment Test (CAT) has been used in COPD consultations to the best effect, presented by Ms Vicki Knowles, Respiratory Clinical Lead, Surrey Community Health (SW Locality).
  • Click here to view this webcast

At the end of each webcast you will be able to print out a certificate, which will provide you with evidence of your learning.

These webcasts were originally developed for and hosted by www.eGuidelines.co.uk in September 2010. Allen & Hanburys supported the development of the webcasts.

Click here to register free of charge for www.eGuidelines.co.uk and access further information on COPD.


The above mentioned webcasts were developed by MGP Ltd and funded by Allen & Hanburys, the Specialist Respiratory Division of GlaxoSmithKline UK. Allen & Hanburys had no editorial input other than reviewing the material for scientific accuracy and ABPI code compliance. The development of the COPD Assessment Test was funded by GlaxoSmithKline group of companies. COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies. ©2009 GlaxoSmithKilne group of companies. All rights reserved.
No part of this publication may be reproduced in any form without the permission of MGP Ltd.


 

 

Page Last Updated: April 25, 2012

COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.

Click Here to take the CATest
 
To print a paper version of CAT, click here. You will need Adobe Acrobat to read this file. Click here to download Adobe Acrobat.
 
If you are a healthcare professional, this guide will show you how to use the CAT in the best way.
GlaxoSmithKline

COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.
Contact us
This website is intended for residents of the UK only.
Please read the legal notices and privacy notices.
Specific medical advice should always be sought from a qualified medical practitioner.
The development of the COPD Assessment Test was funded by GlaxoSmithKline.
GlaxoSmithKline UK Limited. Registered in England. Company No. 4310159.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
Code number: UK/RESP/0014/12 April 2012.